AMLX holders · GOLDMAN SACHS GROUP INC 13F · AMLX stock

GOLDMAN SACHS GROUP INC Amylyx Pharmaceuticals Inc (AMLX) 13F holding

GOLDMAN SACHS GROUP INC reported 1,354,929 AMLX shares valued at $18.83B as of 2026-03-31 (CMN). Cached 13F row, not a live tape.

Cached AMLX reports from GOLDMAN SACHS GROUP INC
ReportSharesValueClass
2026-03-311,354,929$18.83BCMN
2026-03-31894,157$12.43BCMN
2026-03-31376,905$5.24BCMN

Not investment advice. Cached 13F row, not EDGAR XML.